---
title: "Obinutuzumab"
slug: "obinutuzumab"
date: "2023-06-13"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[Management- Symptomatic Stages IIIâ€“IV (or bulky Stage II), Front-line of follicular lymphoma]]

# Obinutuzumab

- Obinutuzumab plus chemotherapy â†’
  - obinutuzumab maintenance should be given if maintenance anti-CD20 therapy is planned.
  - Obinutuzumab-chemo â†’ obinutuzumab maintenance improves PFS
    - compared to rituximab plus chemotherapy â†’ rituximab maintenance
    - (GALLIUM Study, ASH 2016).
